-
News and events
Find out the latest information on our current and past activities and projects as well as recent articles about us, and stories from the field.
Featured
-
-
PATH congratulates Malawi on introducing the first malaria vaccine for African children
Press release23 Apr 2019
Perspectives
Press releases
-
GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine
27 Jan 2021 -
Milestone study identifies immune markers that may help predict success of vaccination with RTS,S/AS01 malaria vaccine
22 Jul 2020 -
PATH receives new five-year contract from USAID for malaria vaccine research and development
7 Jul 2020
Malaria vaccine news
-
A new tool for tricky vaccine development
Imagine if scientists could create their own antibodies – the protein that the immune system creates in order to fight diseases. While it might sound like something out of a science fiction novel, scientists have figured out a way to do it.
PATH29 Nov 2018 -
As the global fight against malaria stalls, malaria vaccine development could be primed for breakout
Malaria has infected humans for a very long time and in more places than many realize. There’s evidence that 3,000 years ago, malaria killed King Tut. It stalked the marshlands and fens of Great Britain and was common in the American South until the middle of the 20th Century.
Global Health Technologies Breakthrough Blog27 Nov 2018 -
Malaria Vaccines: Recent Advances and New Horizons
Leaders in the malaria vaccine field, including PATH’s Rick King, provide an up to the present summary of progress and opportunities. These include some of PATH’s own efforts as well as a rich array of innovative approaches to vaccine discovery, development, and implementation.
Cell Host & Microbe11 Jul 2018
Contact the media office
For press inquiries, please email mvi_info [at] path.org or call Kelsey Mertes at 206-302-4848